香港聯合交易所有限公司
(香港交易及結算所有限公司全資附屬公司)
THE STOCK EXCHANGE OF HONG KONG LIMITED
(A wholly-owned subsidiary of Hong Kong Exchanges and Clearing Limited)

ANNOUNCEMENT

In relation to the matter of
Hua Han Health Industry Holdings Limited
(In Compulsory Liquidation)
(Incorporated in Cayman Islands with limited liability)
(Stock Code: 587)

Cancellation of listing

The Exchange announces that the listing of the Company's shares will be cancelled with effect from 9:00 am on 16 December 2020 under Rule 6.01A.

Trading in the Company’s securities has been suspended since 27 September 2016.

On 20 November 2018, the Securities and Futures Commission (the SFC) exercised its power under section 8(1) of the Securities and Futures (Stock Market Listing) Rules to direct the Exchange to suspend dealings in the shares of the Company.

On 4 August 2020, the High Court of Hong Kong SAR ordered among others to wind up the Company and appoint two representatives of Borrelli Walsh Limited as the Company’s joint and several liquidators under the Companies (Winding Up and Miscellaneous Provisions) (Amendment) Ordinance.

Under Rule 6.01A, the Exchange may delist the Company if trading does not resume by 31 July 2019.  After consultation with the SFC, the Exchange agreed to withhold delisting the Company until 30 October 2020.

The Company failed to fulfill all the resumption conditions and resume trading in its securities by 30 October 2020. On 27 November 2020, the Listing Committee decided to cancel the listing of the Company’s shares on the Exchange under Rule 6.01A.

The Exchange has requested the Company to publish an announcement on the cancellation of its listing.

The Exchange advises shareholders of the Company who have any queries about the implications of the delisting to obtain appropriate professional advice.

Ends